|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▼
|
Registration date ▲
|
Status ▲
|
|
PONESIMOD |
L04AE04 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
BEROTRALSTAT |
B06AC06 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005138 |
30-04-2021 |
VALID
|
|
TRASTUZUMAB DERUXTECAN |
L01FD04 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005124 |
18-01-2021 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
FILGOTINIB |
L04AF04 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/005113 |
24-09-2020 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005095 |
25-05-2022 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
LUMASIRAN |
A16AX18 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/005040 |
19-11-2020 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
SOMAPACITAN |
H01AC07 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005030 |
31-03-2021 |
VALID
|
|
FEDRATINIB |
L01XE57 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
ULIPRISTAL |
G03XB02 |
PT
|
POM
|
14-11-2018 |
EMEA/H/C/005017 |
09-02-2018 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE |
R03AL11 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/004983 |
09-12-2020 |
VALID
|
|
ISATUXIMAB |
L01FC02 |
PT
|
POM
|
05-10-2020 |
EMEA/H/C/004977 |
30-05-2020 |
VALID
|
|
CABOTEGRAVIR |
J05AJ04 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/004976 |
17-12-2020 |
VALID
|
|
BEMPEDOIC ACID AND EZETIMIBE |
C10BA10 |
PT
|
Not authorised
|
10-12-2024 |
EMEA/H/C/004959 |
27-03-2020 |
VALID
|
|
BEMPEDOIC ACID |
C10AX15 |
PT
|
POM
|
09-12-2024 |
EMEA/H/C/004958 |
01-04-2020 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
BROLUCIZUMAB |
S01LA06 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004913 |
13-02-2020 |
VALID
|
|
GLASDEGIB |
L01XX63 |
PT
|
POM
|
05-10-2020 |
EMEA/H/C/004878 |
26-06-2020 |
VALID
|
|
CRIZANLIZUMAB |
B06AX01 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/004874 |
28-10-2020 |
VALID
|
|
ROXADUSTAT |
B03XA05 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/004871 |
18-08-2021 |
VALID
|
|
POLATUZUMAB VEDOTIN |
L01FX14 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004870 |
16-01-2020 |
VALID
|
|
VOXELOTOR |
B06AX03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004869 |
14-02-2022 |
VALID
|
|
CRISABOROLE |
D11AH06 |
PT
|
POM
|
05-10-2020 |
EMEA/H/C/004863 |
27-03-2020 |
VALID
|
|
DELAFLOXACIN |
J01MA23 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004860 |
16-12-2019 |
VALID
|
|
BULEVIRTIDE |
J05AX28 |
PT
|
POM
|
05-10-2020 |
EMEA/H/C/004854 |
31-07-2020 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
CAPMATINIB |
L01EX17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
OZANIMOD |
L04AE02 |
PT
|
POM
|
05-10-2020 |
EMEA/H/C/004835 |
20-05-2020 |
VALID
|
|
CEFIDEROCOL |
J01DI04 |
PT
|
POM
|
05-10-2020 |
EMEA/H/C/004829 |
23-04-2020 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B06XX00 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN |
J07BB02 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004814 |
12-12-2018 |
VALID
|
|
IMIPENEM, CILASTATIN AND RELEBACTAM |
J01DH56 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004808 |
13-02-2020 |
VALID
|
|
LANADELUMAB |
B06AC05 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004806 |
22-11-2018 |
VALID
|
|
DAROLUTAMIDE |
L02BB06 |
PT
|
POM
|
05-10-2020 |
EMEA/H/C/004790 |
27-03-2020 |
VALID
|
|
SATRALIZUMAB |
L04AC19 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/004788 |
24-06-2021 |
VALID
|
|
INOTERSEN |
N07XX15 |
PT
|
POM
|
|
EMEA/H/C/004782 |
27-08-2018 |
VALID
|
|
VILANTEROL, UMECLIDINIUM BROMIDE AND FLUTICASONE FUROATE |
R03AL08 |
PT
|
POM
|
14-11-2018 |
EMEA/H/C/004781 |
08-01-2018 |
VALID
|
|
DACOMITINIB |
L01EB07 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004779 |
01-04-2019 |
VALID
|
|
GIVOSIRAN |
A16AX16 |
PT
|
POM
|
05-10-2020 |
EMEA/H/C/004775 |
02-03-2020 |
VALID
|
|
FIDANACOGENE ELAPARVOVEC |
B02BD17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004774 |
24-07-2024 |
VALID
|
|
DURVALUMAB |
L01FF03 |
PT
|
POM
|
14-11-2018 |
EMEA/H/C/004771 |
20-09-2018 |
VALID
|
|
UPADACITINIB |
L04AF03 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004760 |
16-12-2019 |
VALID
|
|
GILTERITINIB |
L01EX13 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004752 |
24-10-2019 |
VALID
|
|
ONASEMNOGENE ABEPARVOVEC |
M09AX09 |
PT
|
POM
|
05-10-2020 |
EMEA/H/C/004750 |
18-05-2020 |
VALID
|
|
DORAVIRINE |
J05AG06 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004747 |
22-11-2018 |
VALID
|
|
LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE |
J05AR24 |
PT
|
POM
|
05-06-2020 |
EMEA/H/C/004746 |
22-11-2018 |
VALID
|